Sermorelin / Ipamorelin Blend is a research peptide formulation combining two well-studied synthetic peptides commonly examined in growth hormone and endocrine signaling research: Sermorelin and Ipamorelin. Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, this blend is formulated for laboratory research focused on pulsatile growth hormone release, receptor signaling pathways, and coordinated endocrine response mechanisms.
Prior to the targeted synthesis and study of these peptides, research into growth hormone modulation relied largely on less selective secretagogues and broader hormonal interventions. In controlled research settings, Sermorelin has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a relatively short duration of activity. Ipamorelin has been examined for its selective receptor activity and minimal interaction with other pituitary hormones. The combination allows researchers to examine complementary mechanisms involved in growth hormone pulsatility, secretion dynamics, and endocrine signaling coordination.
Currently, the Sermorelin / Ipamorelin Blend is being investigated for potential applications in metabolic research models, endocrine pathway analysis, recovery-related signaling studies, and age-associated hormone regulation research. Additional investigation continues into its role in downstream anabolic signaling, circadian hormone release patterns, and coordinated pituitary response mechanisms. Due to the complementary research interest of these peptides, this blend remains a compelling subject for ongoing laboratory investigation.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
The Sermorelin, Ipamorelin (5mg / 5mg) Blend is designed for laboratory research investigating growth hormone axis signaling, hypothalamic–pituitary communication pathways, and endocrine biomarker behavior in controlled experimental models. By combining a growth hormone–releasing hormone analog with a growth hormone secretagogue, this peptide blend allows researchers to study how complementary signaling mechanisms influence pulsatile growth hormone release.
Multi-peptide research protocols are frequently used in endocrine and metabolic research environments to analyze how upstream hypothalamic signaling interacts with pituitary hormone release mechanisms. When applied within carefully structured experimental frameworks, this combination may help researchers observe hormone pulse patterns, receptor signaling activity, and downstream biomarker responses.
Sermorelin, Ipamorelin (5mg / 5mg) Blend – Research Specifications:
| Format | Lyophilized peptide blend (research format) |
| Contents | Sermorelin (5mg) + Ipamorelin (5mg) |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical documentation |
| Source | Peptide synthesis under controlled laboratory manufacturing standards |
| Appearance | Lyophilized powder |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human or veterinary applications. |
Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) commonly studied in laboratory environments examining hypothalamic–pituitary axis signaling. Research models may evaluate how Sermorelin stimulates upstream signaling pathways that regulate pulsatile growth hormone release.
Ipamorelin is a selective growth hormone secretagogue that interacts with ghrelin receptors involved in growth hormone signaling pathways. In research environments, Ipamorelin is frequently studied for its role in stimulating GH release with minimal interaction with other endocrine pathways.
When combined within a research model, Sermorelin and Ipamorelin allow investigators to examine how hypothalamic signaling interacts with ghrelin receptor activation. These experimental models may analyze growth hormone pulse frequency, secretion amplitude, and downstream endocrine biomarker responses.
Researchers examining these peptides individually may reference the product pages for Sermorelin and Ipamorelin.
Important Research Notice: Nordsci peptide products are supported by lot-specific analytical documentation. Certificates of Analysis are available to assist laboratories with procurement verification and research reproducibility tracking.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
A primary research objective for this peptide blend involves evaluating pulsatile growth hormone release. Researchers may analyze endocrine marker fluctuations across timed sampling intervals to understand how combined signaling pathways influence hormone pulse dynamics.
Because Sermorelin stimulates upstream GHRH pathways while Ipamorelin activates ghrelin receptor signaling, this blend provides a useful experimental framework for studying multi-pathway endocrine communication.
Growth hormone research protocols often include measurement of downstream endocrine biomarkers. Researchers may evaluate hormonal markers associated with GH-axis signaling following peptide pathway activation.
Some laboratory protocols compare peptide blends with single-compound experiments. This approach allows researchers to determine whether observed hormone signaling responses result from individual peptides or from combined pathway interactions.
The Sermorelin, Ipamorelin Blend should be handled according to standard peptide laboratory procedures, including contamination prevention, proper storage conditions, and detailed documentation of experimental variables. Maintaining controlled laboratory environments helps support reproducible research outcomes.
Protocol Design Considerations: Growth hormone signaling research is influenced by circadian rhythm patterns, metabolic baseline conditions, environmental stress factors, and experimental timing. Carefully structured protocols are essential for accurate endocrine data interpretation.
Note: The information provided here is intended solely for laboratory research reference. All experiments should be conducted by qualified professionals within appropriate research facilities.
Each lot of this peptide blend includes a Certificate of Analysis verifying peptide identity and quality parameters. These analytical reports assist laboratories with procurement validation, regulatory documentation, and research reproducibility support.
Laboratories sourcing peptides for endocrine research typically prioritize consistent synthesis standards, reliable quality control, and transparent analytical documentation. Nordsci Peptides provides research-grade peptide materials supported by laboratory testing protocols designed to support reproducible scientific research.
IMPORTANT: This product is supplied exclusively for laboratory research use. It is not approved for human consumption or clinical application. Researchers are responsible for ensuring compliance with all institutional and regulatory guidelines.
